medigraphic.com
SPANISH

Médica Sur

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number 2

<< Back Next >>

Med Sur 2013; 20 (2)

Lesiones hepáticas benignas: incidencia y características clínicas. Seguimiento de seis años en la Fundación Clínica Médica Sur

Motola-Kuba M, Manzano-Robleda MC, Aguilar-Olivos NE, Toapanta-Yanchapaxi L, Ornelas-Arroyo S, Chable-Montero F, Uribe-Esquivel M, Lizardi-Cervera J
Full text How to cite this article

Language: Spanish
References: 5
Page: 100-102
PDF size: 126.10 Kb.


Key words:

Tumor, Hemangioma, Liver.

ABSTRACT

Background. Liver benign tumors are lesions of different clinical and epidemiological characteristics. Hemangiomas are the most common and adenomas are injuries that can cause bleeding and subsequent malignancy. Objective. Describe the prevalence of various benign liver lesions over a period of six years in the Medica Sur Clinic and Foundation. Analyze the demographic, clinical and biopsy or surgery indications. Material and methods. Retrospective study in which was included benign liver lesions cases from Pathology files at Medica Sur Clinic during the period from January 2006 to July 2012. Descriptive statistics were employed to analyzed demographic, clinical and diagnostic procedures performed generally and by subgroup. Results. Of 30 patients, the hemangioma was the most common injury (37%); 73% of these patients had pain as an initial sign. Adenoma was clinically tumor hemorrhage debuted. The 50% with focal nodular hyperplasia reported using oral contraceptives. Conclusions. Benign liver tumors are usually discovered incidentally or in the context of low-specific symptomatology. The risk complicating tumor is very low and generally corresponds to the presence of adenomas.


REFERENCES

  1. Van Aalten SM, De Man RA, IJzermans JN, Terkivatan T. Systematic review of haemorrhage and rupture of hepatocellular adenomas. Br J Surg 2012; 99(7): 911-6.

  2. Bonder A, Afdhal N. Evaluation of liver lesions. Clin Liver Dis 2012; 16(2): 271-83.

  3. Cristiano A, Dietrich A, Spina JC, Ardiles V, de Santibañes E. Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management. Updates Surg 2013.

  4. Chang CY, Hernandez-Prera JC, Roayaie S, Schwartz M, Thung SN. Changing epidemiology of hepatocellular adenoma in the United States: review of the literature. Int J Hepatol 2013.

  5. Nault JC, Bioulac-Sage P, Zucman-Rossi J. Hepatocellular benign tumors-from molecular classification to personalized clinical care. Gastroenterology 2013; 144(5).




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Sur. 2013;20